In April 2006 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) changed to Canadian Agency for Drugs and Technologies in Health (CADTH)
Raloxifene for primary and secondary prevention of osteoporotic fractures in postmenopausal women : a systematic review of efficacy and safety evidence